U.S. Electric Utilities Stock News

Pomerantz LLP is examining potential securities law issues at Caledonia Mining (CMCL), while Zimbabwe’s latest budget limits royalty changes to very high gold prices, putting both legal and fiscal risks in sharper focus for investors. See our latest analysis for Caledonia Mining. The recent legal inquiry and shifting royalty outlook come after a volatile period, with an 18.01% 1 month share price return but a 15.80% 3 month share price decline, while the 1 year total shareholder return of...

Orchid Island Capital overview Orchid Island Capital (ORC) has attracted fresh attention after recent share price moves, with the stock showing mixed short term returns and a longer performance record that may prompt income focused investors to reassess its risk reward profile. See our latest analysis for Orchid Island Capital. Recent trading has been relatively firm, with a 30 day share price return of 3.89% and a 90 day share price return of 5.51%. The 1 year total shareholder return of...

Under Armour (UAA) is back in focus after Fairfax Financial Holdings lifted its stake to more than 22% and the company recently reported earnings that topped analyst expectations, highlighting early brand momentum in North America. See our latest analysis for Under Armour. The recent Fairfax buying, earnings beat and a break above the 200 day moving average have coincided with a 39.21% 30 day share price return. However, the 1 year total shareholder return of a 25.83% decline and deeper three...

In recent months, Public Storage, a major US self-storage REIT, has drawn attention for continued facility acquisitions, technology investments, and disciplined rent optimization amid sector concerns about occupancy and interest rates. What stands out is how the company’s steady acquisition pace and digital focus are being weighed directly against rising occupancy risk and funding costs. We’ll now examine how this focus on occupancy resilience and interest rate uncertainty could influence...

Ascendis Pharma (ASND) is back in focus after releasing Week 52 topline data from its COACH Phase 2 trial, in which once weekly TransCon CNP plus TransCon hGH in children with achondroplasia showed durable growth and maintained a consistent safety profile. See our latest analysis for Ascendis Pharma. The COACH data arrive at a time when Ascendis Pharma’s share price sits at US$208.75, after a 6.16% 1 month share price return but a slightly negative year to date move. The 1 year total...

Bread Financial Holdings (BFH) stock moved after Goldman Sachs upgraded the company, citing improvements in its credit profile and capital position, along with stronger sentiment toward financial names connected to potential rate cuts. See our latest analysis for Bread Financial Holdings. The Goldman Sachs upgrade comes after a strong rebound in Bread Financial’s share price, with a 90 day share price return of 50.24% and a 1 year total shareholder return of 39.11%. This suggests momentum has...

Unusual Machines (UMAC) is drawing attention after short interest climbed to 16.42% of its float, as the company prepares for the Needham Growth Conference and adjusts its leadership team in the drone sector. See our latest analysis for Unusual Machines. The recent leadership change and conference appearance follow a 30 day share price return of 43.44% and a 1 year total shareholder return of 16.08%. This suggests momentum has picked up in the short term despite elevated short interest. If...

Analyst sentiment around DuPont de Nemours (DD) has turned more supportive, with UBS reaffirming its positive view and other firms backing the stock, even as PFAS-related litigation risk remains part of the overall picture. See our latest analysis for DuPont de Nemours. At a share price of $43.40, DuPont de Nemours has seen short term momentum pick up, with a 7 day share price return of 7.96% and 30 day share price return of 6.87%. In contrast, the 90 day share price return shows a decline of...

Hyperscale Data (GPUS) is back in focus after releasing preliminary year end asset estimates, detailing a Bitcoin treasury that now exceeds its market capitalization and pledging more frequent balance sheet updates through 2026. See our latest analysis for Hyperscale Data. The latest balance sheet update and Bitcoin focus come after a volatile period, with a 93.68% 7 day share price return and a 30.26% year to date share price return, set against a 1 year total shareholder return of...

Why Fiverr International (FVRR) is drawing attention ahead of earnings Fiverr International (FVRR) has caught investors’ attention after a 7.05% single day share price decline, even as the broader market gained, with expectations building around its forthcoming earnings release. See our latest analysis for Fiverr International. The recent 1 month share price return of 16.33% and 3 month share price return of 19.56% set the backdrop for a much weaker 1 year total shareholder return of 42.72%...

What Castle Biosciences stock’s recent move might be telling you Castle Biosciences (CSTL) has drawn fresh attention after a strong past 3 months, with the share price moving alongside solid reported annual revenue growth and improving net income, prompting investors to reassess the story. See our latest analysis for Castle Biosciences. That recent 72.83% 90 day share price return stands out against a more modest 21.91% 1 year total shareholder return and a 53.25% total shareholder return...

With no single headline event setting the tone, Yum China Holdings (YUMC) has drawn attention through its recent share performance and fundamentals, prompting investors to reassess how its current valuation lines up with reported results. See our latest analysis for Yum China Holdings. At a share price of $48.0, Yum China Holdings has seen a 12.57% 90 day share price return and a 12.45% 1 year total shareholder return, which may indicate changing momentum alongside a slightly negative year to...

If you have been wondering whether Pony AI at around US$17.29 is priced attractively or not, this article walks through the numbers so you can judge the value for yourself. Pony AI’s share price sits at US$17.29, with returns of 19.2% over 7 days, 21.8% over 30 days, 7.6% year to date, and 26.6% over the last year, which has put the stock on more radars recently. These moves come alongside ongoing interest in autonomous driving companies and fresh commentary on how self driving technology...

In the past week, Corpay reported third-quarter 2025 results that exceeded consensus expectations on both adjusted earnings per share and revenue, while director Stull Steven T purchased 8,000 shares for about US$2.5 million, increasing his direct ownership. Together with renewed attention from institutional investors such as Vltava Fund, these developments have reinforced interest in Corpay’s recurring, automation-focused business payments platform and its long-term customer relationships...

AI demand reshapes Teradyne’s business mix Recent commentary points to a structural shift at Teradyne (TER). Rising AI chip complexity and a Compute/Memory segment now near 60% of revenue are reshaping how investors think about the company’s core testing franchise. See our latest analysis for Teradyne. TER’s share price has had a mixed near term patch, with a 1 day share price decline of 2.77%, a 90 day share price return of 63.77%, and a 1 year total shareholder return of 58.40%. This...

If you are wondering whether Domino's Pizza stock is a fair deal at current levels, you are not alone. Many investors are trying to work out what they are really paying for with each share. The share price closed at US$406.58, with a 2.5% decline over 7 days, a 2.5% decline over 30 days, a 4.4% decline year to date, and a 0.1% gain over the past year, while the 3 year and 5 year returns sit at 25.7% and 15.9% respectively. Recent attention on Domino's Pizza has been shaped by its long term...

In December 2025, Riot Platforms sold 1,818 Bitcoin for net proceeds of US$161.6 million and produced 460 Bitcoin, while also appointing Jason Chung as incoming CFO and completing over US$600.53 million in follow-on equity offerings to support its evolving operations. The company’s record Bitcoin liquidation, pivot toward AI-focused data center infrastructure, and shift to quarterly reporting mark a material reorientation of its business model and leadership incentives away from pure Bitcoin...

Lumen Technologies (LUMN) is in the spotlight after it moved to sell its remaining consumer fiber network to AT&T, while its Level 3 unit issues senior notes to repurchase existing debt and reshape the balance sheet. See our latest analysis for Lumen Technologies. The recent asset sale plans and debt reshaping efforts come after a mixed share price pattern, with a 24.16% 90 day share price return and a 48.01% 1 year total shareholder return suggesting that momentum may still be building. If...

Arcutis Biotherapeutics (ARQT) has drawn fresh investor attention after reporting strong revenue growth tied to its dermatology pipeline, with lead product ZORYVE playing a central role even as the company continues to post operating losses. See our latest analysis for Arcutis Biotherapeutics. The recent dermatology update comes after a strong 90 day share price return of 49.03% and a 1 year total shareholder return of 95.68%. This suggests momentum has been building around Arcutis...

In recent days, NOV has attracted renewed attention from Wall Street as multiple research firms updated their views on the company and reaffirmed their outlooks based on recent operational and industry developments. This cluster of analyst revisions highlights a shift in how the market is interpreting NOV’s position in the energy equipment landscape and its potential to execute on current opportunities and challenges. We’ll now explore how this improving analyst sentiment shapes NOV’s...

AMC Entertainment Holdings (AMC) is back in focus after its shares hit an all time low, even as the company reported its strongest pre Christmas weekend box office since 2021 on Avatar: Fire and Ash. See our latest analysis for AMC Entertainment Holdings. That mix of record pre Christmas box office and a new all time low share price has come after a sharp reset in expectations, with a 30 day share price return of 36.4% and a 1 year total shareholder return decline of 63.3%, suggesting...

AGCO’s AE50 awards and what they might mean for the stock AGCO (AGCO) recently received seven 2026 AE50 awards from the American Society of Agricultural and Biological Engineers, spotlighting its agricultural machinery and technology across Fendt, Massey Ferguson and PTx brands. For investors, this kind of industry recognition can be a useful prompt to reassess how AGCO’s product portfolio, financial profile and current valuation align with expectations for future demand and...

Immuneering (IMRX) is back on traders’ screens after releasing updated Phase 2a data for atebimetinib plus modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer, showing higher overall survival and response metrics than standard benchmarks. See our latest analysis for Immuneering. The updated atebimetinib data arrive after a tough recent stretch, with the share price at US$4.73 and a 1 day share price return of 43.22% decline. However, a 1 year total shareholder return of 136.5%...

If you are wondering whether Hewlett Packard Enterprise at around US$22 is offering good value today, you are in the right place to get a clear, valuation focused view. The stock has had a mixed run, with a 7 day return of an 8.3% decline and a 30 day return of an 11.1% decline, while the longer term picture shows a 1 year return of 2.6%, around 46.8% over 3 years and about 104.5% over 5 years. Recently, Hewlett Packard Enterprise has been in the news for its ongoing role as a key...